Robert Henningsen

3.5k total citations · 1 hit paper
20 papers, 2.9k citations indexed

About

Robert Henningsen is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Robert Henningsen has authored 20 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Cellular and Molecular Neuroscience and 2 papers in Organic Chemistry. Recurrent topics in Robert Henningsen's work include Receptor Mechanisms and Signaling (10 papers), Neuropeptides and Animal Physiology (7 papers) and Neuroscience and Neuropharmacology Research (4 papers). Robert Henningsen is often cited by papers focused on Receptor Mechanisms and Signaling (10 papers), Neuropeptides and Animal Physiology (7 papers) and Neuroscience and Neuropharmacology Research (4 papers). Robert Henningsen collaborates with scholars based in United States, Switzerland and Italy. Robert Henningsen's co-authors include Olivier Civelli, Frederick J. Monsma, Rainer K. Reinscheid, Ali Ardati, Hans‐Peter Nothacker, James R. Bunzow, Anne Bourson, David K. Grandy, Hanno Langen and Kim A. Neve and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Robert Henningsen

20 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Orphanin FQ: A Neuropeptide That Activates an Opioidlike G Protein-Coupled Receptor

1995 1.6k citations Rainer K. Reinscheid, Hans‐Peter Nothacker et al. Science profile →

Peers

Countries citing papers authored by Robert Henningsen

Since Specialization

Citations

This map shows the geographic impact of Robert Henningsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Henningsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Henningsen more than expected).

Fields of papers citing papers by Robert Henningsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Henningsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Henningsen. The network helps show where Robert Henningsen may publish in the future.

Co-authorship network of co-authors of Robert Henningsen

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Henningsen. A scholar is included among the top collaborators of Robert Henningsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Henningsen. Robert Henningsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting CD74 in B-cell non-Hodgkin lymphoma with the antibody-drug conjugate STRO-001 2023 ·Oncotarget ·Xiaofan Li, Cristina L. Abrahams, Abigail Yu, Millicent Embry, Robert Henningsen, Venita DeAlmeida, Shannon Matheny, Toni Kline, Alice Yam, Ryan Stafford, Trevor J. Hallam, Mark Lupher, Arturo Molina	5
2	High Frequency of CD74 Expression in B-Cell Non-Hodgkin's Lymphoma (NHL) and Targeting with SΤRO-001, a Novel Anti-CD74 Antibody Drug Conjugate (ADC) with Potent I n Vitro Cytotoxicty and In Vivo Anti-Tumor Activity 2017 ·Blood ·Abigail Yu, Cristina L. Abrahams, Millicent Embry, Xiaofan Li, Shuchun Zhao, Robert Henningsen, Venita DeAlmeida, Shannon Matheny, Toni Kline, Alice Yam, Ryan Stafford, Yasodha Natkunam, Trevor J. Hallam, Mark Lupher, Arturo Molina	1
3	Engineering Highly Potent and Selective Microproteins against Nav1.7 Sodium Channel for Treatment of Pain 2016 ·Journal of Biological Chemistry ·Anatoly Shcherbatko, Andrea Rossi, Davide Foletti, Guoyun Zhu, Oren Bogin, Meritxell Galindo Casas, Mathias Rickert, Adela Hasa-Moreno, Victor V. Bartsevich, Andreas Crameri, Alexander Steiner, Robert Henningsen, Avinash Gill, Jaume Pons, David L. Shelton, Arvind Rajpal, Pavel Strop	42
4	Scaffold hopping towards potent and selective JAK3 inhibitors: Discovery of novel C-5 substituted pyrrolopyrazines 2014 ·Bioorganic & Medicinal Chemistry Letters ·Javier de Vicente, Rémy C. Lemoine, Mark J. Bartlett, Johannes C. Hermann, Mohammad Hekmat-Nejad, Robert Henningsen, Sue Jin, A. Kuglstatter, Hong‐Ju Li, Allen Lovey, John G. Menke, Linghao Niu, Vaishali Patel, Ann Petersen, (unknown), (unknown), (unknown), Minh Diem Vu, Michael Soth	20
5	AF‐353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist 2010 ·British Journal of Pharmacology ·Joel R. Gever, (unknown), Robert Henningsen, Renée S. Martin, David H. Hackos, Sandip Panicker, Werner Rubas, Ian B. Oglesby, Michael P. Dillon, Marcos E. Milla, Geoffrey Burnstock, Anthony Ford	108
6	Biochemical characterization of the inhibition of the dengue virus RNA polymerase by beta-d-2′-ethynyl-7-deaza-adenosine triphosphate 2010 ·Antiviral Research ·(unknown), Andreas Jekle, Hassan Javanbakht, Robert Henningsen, Peter Gee, (unknown), (unknown), Suping Ren, Alan K. Kutach, Seth F. Harris, (unknown), (unknown), David E. Shaw, Jim Zhang Hao Li, Gabrielle Heilek, Klaus Klumpp, David C. Swinney, Jérôme Deval	35
7	Antidepressants Targeting the Serotonin Reuptake Transporter Act via a Competitive Mechanism 2008 ·Journal of Pharmacology and Experimental Therapeutics ·Subbu Apparsundaram, (unknown), Robert Henningsen, Marcos E. Milla, Renée S. Martin	51
8	Kinetic and Thermodynamic Assessment of Binding of Serotonin Transporter Inhibitors 2008 ·Journal of Pharmacology and Experimental Therapeutics ·Renée S. Martin, Robert Henningsen, (unknown), Subbu Apparsundaram, (unknown), (unknown), Rama K. Kondru, Marcos E. Milla	24
9	Application of zwitterionic detergents to the solubilization of integral membrane proteins for two-dimensional gel electrophoresis and mass spectrometry 2002 ·PROTEOMICS ·Robert Henningsen, (unknown), Kenneth Straub, Diane C. DeNagel	69
10	Structures That Delineate Orphanin FQ and Dynorphin A Pharmacological Selectivities 1998 ·Journal of Biological Chemistry ·Rainer K. Reinscheid, Jacqueline Higelin, Robert Henningsen, Frederick J. Monsma, Olivier Civelli	100
11	Characterization of [³H]‐(2S,2′R,3′R)‐2‐(2′,3′‐dicarboxy‐ cyclopropyl)glycine ([³H]‐DCG IV) binding to metabotropic mGlu₂ receptor‐transfected cell membranes 1998 ·British Journal of Pharmacology ·Jayne Cartmell, Geo Adam, Sylvie Chaboz, Robert Henningsen, John A. Kemp, (unknown), (unknown), Frederick J. Monsma, Hervé Schaffhauser, Jürgen Wichmann, Vincent Mutel	66
12	Expression and characterization of a dopamine D4R variant associated with delusional disorder 1998 ·FEBS Letters ·Marie‐Thérèse Zenner, Maria Nobile, Robert Henningsen, Enrico Smeraldi, Olivier Civelli, Deborah Hartman, Marco Catalano	15
13	Interaction of [3H]Orphanin FQ and125I-Tyr14-Orphanin FQ with the Orphanin FQ Receptor: Kinetics and Modulation by Cations and Guanine Nucleotides 1997 ·Molecular Pharmacology ·Ali Ardati, Robert Henningsen, Jacqueline Higelin, Rainer K. Reinscheid, Olivier Civelli, Frederick J. Monsma	52
14	Primary structure and tissue distribution of the orphanin FQ precursor. 1996 ·Proceedings of the National Academy of Sciences ·Hans‐Peter Nothacker, Rainer K. Reinscheid, Alfred Mansour, Robert Henningsen, Ali Ardati, Frederick J. Monsma, Stanley J. Watson, Olivier Civelli	218
15	Orphanin FQ: A Neuropeptide That Activates an Opioidlike G Protein-Coupled Receptor breakdown → 1995 ·Science ·Rainer K. Reinscheid, Hans‐Peter Nothacker, Anne Bourson, Ali Ardati, Robert Henningsen, James R. Bunzow, David K. Grandy, Hanno Langen, Frederick J. Monsma, Olivier Civelli	1596
16	Release of dopamine via the human transporter. 1994 ·Molecular Pharmacology ·Amy J. Eshleman, Robert Henningsen, Kim A. Neve, Aaron Janowsky	136
17	Contributions of Conserved Serine Residues to the Interactions of Ligands with Dopamine D2 Receptors 1992 ·Journal of Neurochemistry ·Barbara Cox, Robert Henningsen, (unknown), Rachael L. Neve, Kim A. Neve	108
18	Pivotal role for aspartate-80 in the regulation of dopamine D2 receptor affinity for drugs and inhibition of adenylyl cyclase. 1991 ·Molecular Pharmacology ·Kim A. Neve, Barbara Cox, Robert Henningsen, (unknown), Rachael L. Neve	165
19	Sodium-dependent isomerization of dopamine D-2 receptors characterized using [125I]epidepride, a high-affinity substituted benzamide ligand. 1990 ·Journal of Pharmacology and Experimental Therapeutics ·Kim A. Neve, Robert Henningsen, J. Mark Kinzie, Tomas de Paulis, (unknown), Robert Kessler, Aaron Janowsky	54
20	Functional characterization of a rat dopamine D-2 receptor cDNA expressed in a mammalian cell line. 1989 ·Molecular Pharmacology ·Kim A. Neve, Robert Henningsen, James R. Bunzow, Olivier Civelli	60

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact